Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion type Assertion NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_head.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion description "[Our study highlights the genomic profile as a predictor for clinical outcome and suggests that genome scanning of chromosomes 1p21, 9q21-q22, 9p21.3-P16/INK4a, and 17p13.1-TP53 may be clinically useful in MCL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_provenance.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion evidence source_evidence_literature NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_provenance.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion SIO_000772 15718413 NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_provenance.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion wasDerivedFrom befree-2016 NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_provenance.
- NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_assertion wasGeneratedBy ECO_0000203 NP481412.RA0JVj-7fhSNhxRyQ3et_6RtowwDPj6-EUvJVV3bmJ2aM130_provenance.